68
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Suspicious Urine Cytology (Class III) in Patients with Bladder Cancer: Should it be Considered as Negative or Positive?

, , , , , & show all
Pages 213-217 | Published online: 09 Jul 2009

REFERENCES

  • Papanicolaou GN, Marshall VF. Urine sediment smears: a diagnostic procedure in cancers of the urinary tract. Science 1945; 101: 519–20.
  • Murphy W. Current status of urinary cytology in evaluation of bladder neoplasms. Hum Pathol 1990; 21: 886–96.
  • Umiker W. Accuracy of cytological diagnosis of cancer of the urinary tract. Acta Cytol 1964; 8: 186–96.
  • Wiener HG, Vooijs GP, Hof-Grootenboer B. Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer. Acta Cytol 1993; 37:163–9.
  • Mostofi FK, Sobin LH, Torloni H. Histological typing of urinary bladder tumours. Geneva: World Health Orga-nization; 1973
  • Union Internationale Contre le Cancer. TNM Classifica-tion of Malignant Tumors. 3rd ed. Geneva: International Union Against Cancer; 1978.
  • Heney NM, Nocks BN, Daly JJ, Prout GR Jr, Newall JB, Griffin BB, Perrone TL, Szyfelbein WA. Ta and Ti bladder cancer: location, recurrence and progression. Br J Urol 1982; 54: 152–7.
  • Lutzeyer W, Rubben H, Dahm H. Prognostic parameters in superficial bladder cancer: an analysis on 315 cases. J Urol 1982; 127: 250–2.
  • Trott PA, Edvards L. Comparison of bladder washings and urine cytology in the diagnosis of bladder cancer. J Urol 1973; 110: 664–6.
  • Koss LG, Deitch D, Ramanathan R, Sherman AB. Diagnostic value of cytology of voided urine. Acta Cytol 1985; 29: 810–16.
  • Raitanen M-P, Marttila T, Nurmi M, Ala-Opas M, Nieminen P, Aine R, Tammela TLJ. Human complement factor H related protein (BTA stat) test in monitoring of bladder cancer. J Urol 2001; 165: 374–7.
  • Leyh H, Marberger M, Conort P, Sternberg C, Pansadoro V, Pagano F, Bassi P, Boccon-Gibod L, Ravery V, Treiber U, Ishak L. Comparison of the BTA stat Test with voided urine cytology and bladder wash cytology in the diagnosis and monitoring of bladder cancer. Eur Urol 1999; 35: 52–6.
  • Giannopolou A, Manousakas T, Mitropoulos D, Botsoli-Stergiou E, Constantinides C, Giannopoulou M, Chor-emi-Papadopoulou H. Comparative evaluation of the BTA stat Test, NMP 22, and voided urine cytology in the detection of primary and recurrent bladder tumors. Urol 2000; 55: 871–5.
  • Tyrkk8 J. Exfoliative cytology in the diagnosis and follow-up of urothelial neoplasms (doctoral thesis). Scand J Urol Nephrol 1972; 19 suppl.
  • Serretta V, Pomara G, Rizzo I, Esposito E. Urinary BTA-stat, BTA-trak and NMP 22 in surveillance after TUR of recurrent superficial transitional cell carcinoma of the bladder. Eur Urol 2000; 38: 419–25.
  • Ramakurnar S, Bhuiyan J, Besse JA, Roberts SG, Wollan BC, Blute ML, O'Kane DJ. Comparison of screening methods in the detection of bladder cancer. J Urol 1999; 161: 388–94.
  • Sharma S, Zippe CD, Pandrangi L, Nelson D, Agarwal A. Exclusion criteria enhance the specificity and positive predictive value of NMP 22 and BTA stat. J Urol 2000; 162: 53–7.
  • Raitanen M-P, Marttila T, Kaasinen E, Rintala E, Aine R, Tammela TLJ. Sensitivity of human complement factor H related protein (the BTA stat Test) test and voided urine cytology in the diagnosis of bladder cancer. J Urol 2000; 163: 1689–92.
  • Pode D, Shapiro A, Wald M, Nativ O, Laufer M, Kaver I. Noninvasive detection of bladder cancer with the BTA stat test. J Urol 1999; 161: 443–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.